The 22 references in paper T. Gaygolnik V., I. Demko V., E. Bochanova N., A. Kraposhina Yu., N. Gordeeva V., I. Soloveva A., Т. Гайгольник В., И. Демко В., Е. Бочанова Н., А. Крапошина Ю., Н. Гордеева В., И. Соловьева А. (2016) “Фармакоэкономический анализ затрат на обеспечение льготными лекарственными препаратами больных хронической обструктивной болезнью легких на территории Красноярского края // PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION” / spz:neicon:pharmacoeconomics:y:2016:i:2:p:49-59

1
Vorob'ev P. A. Clinical economic analysis [Klinikoekonomicheskii analiz (in Russian)]. Moscow. 2008; 778 s.
(check this in PDF content)
2
Gajgol'nik T. V., D emko I. V., Bochanova E. N., Gordeeva N. V., Kraposhina A. Ju., Solov'eva I. A. Pul'monologija. 2015, 3: 320-326.
(check this in PDF content)
3
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2014. URL: http://www.goldcopd. org/uploads/users/files/GOLD_2014.pdf. Accessed: 20.11.2015.
(check this in PDF content)
4
Report of World Health Organization. Chronic Obstructive Pulmonary Disease (COPD): Informacionnyj bjulleten' No315, — 2015g. URL: http://www.who.int/mediacentre/factsheets/fs315/ru/. Accessed: 20.11.2015.
(check this in PDF content)
5
Kozlov R. S., Krechikova O. I., Sivaja O. V., Krechikova O. I., Gudkov I. V.; Strachunskij L. S., Agapova E. D., Rozanova S. M., Furletova N. M., Gudkova L. V., Gugucidze E. N., Egorova R. R., Il'ina V. N., Katosova L. K., Manerov F. K., Marusina N. E., Multyh I. G., Nehaeva G. I., Nurtdinova N. M., Paljutin Sh. H., Smirnov I. V., Shhetinin E. V., Shturmina S. M., Ceneva G. Ja., Dzjublik A. Ja., Simonov S. S., Perceva T. A. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2002, 3(4): 267-277.
(check this in PDF content)
6
Krysanov I. S. Kachestvennaja klinicheskaja praktika. 2014; 2: 51-56.
(check this in PDF content)
7
Chuchalin A. G., Ajsanov Z. R., Avdeev S. N., Belevskij A. S., Leshhenko I. V., Meshherjakova N. N., Ovcharenko S. I., Shmelev E. I. Pul'monologija. 2014; 3: 15-36.
(check this in PDF content)
8
Artyukhov I. P., Arshukova I. L., Dobretsova E. A., Dugina T. A., Shulmin A. V., Demko I. V. Epidemiology of chronic obstructive pulmonary dis ease: a population-based study in Krasnoyarsk region, Russia. Int. J. Chron. Obstruct. Pulmon. Dis. 2015; 10 (1): 1781-1786.
(check this in PDF content)
9
Asche C. V., Leader S., Plauschinat C., Raparla S., Yan M., Ye X., Young D. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids. Int. J. Chron. Obstruct Pulmon. Dis. 2015; 10 (1): 1093-1102.
(check this in PDF content)
10
Barr R. G., Bourbeau J., Camargo C. A., Ram F. S. Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis. Thorax. 2006; 61 (10): 854-862.
(check this in PDF content)
11
Bettoncelli G., Blasi F., Brusasco V., Centanni S., Corrado A., De Benedetto F., De Michele F., U Di Maria G., F Donner C., Falcone F., Mereu C., Nardini S., Pasqua F., Polverino M., Rossi A., Sanguinetti C. M. The clinical and integrated management of COPD. An official document of AIMAR (Interdisciplinary Association for Research in Lung Disease), AIPO (Italian Association of Hospital Pulmonologists), SIMER (Italian Society of Respiratory Medicine), SIMG (Italian Society of General Medicine). Sarcoidosis Vasc. Diffuse Lung Dis. 2014; 31 (1): 3-21.
(check this in PDF content)
12
Chuchalin A. G., Khaltaev N., Antonov N. S., Galkin D. V., Manakov L. G., Antonini P., Murphy M., Solodovnikov A. G., Bousquet J., Pereira M. H. S., Demko I. V. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9 (1): 963-974.
(check this in PDF content)
13
Cosio М., Baraldo S., Saetta M. Inhaled Glucocorticoids and COPD Exacerbations. N Engl J Med. 2015; 372: 92-94.
(check this in PDF content)
14
Hizawa N. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes. Int. J. Chron. Obstruct. Pulmon. Dis. 2015; 10 (1): 1093-1102.
(check this in PDF content)
15
Kew K. M., Seniukovich A. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014; 3: CD010115.
(check this in PDF content)
16
Magnussen H., Disse B., Rodriguez-Roisin R., Kirsten A., Watz H., Tetzlaff K., Towse L., Finnigan H., Dahl R., Decramer M., Chanez P., Wouters E. F., Calverley P. M. Investigators.et al. Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N Engl J Med. 2014; 371: 1285-1294.
(check this in PDF content)
17
Pascoe S., Locantore N., Dran sfield M., Barnes N. C., Pavord I. D. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015; 3: 43544 2.
(check this in PDF content)
18
Perera P. N., Armstrong E. P., Sherrill D. L., Skrepnek G. H. Acute Exacerbations of COPD in the United States: Inpatient Burden and Predictors of Costs and Mortality. Int. J. Chron. Obstruct. Pulmon. Dis. 2012; 9 (2): 131-141.
(check this in PDF content)
19
Poole P., Chong J., Cates C. J. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2015, Issue 7. Art. No.: CD001287. DOI: 10.1002/14651858.CD001287.pub5. URL: http:// onlinelibrary.wiley.com/enhanced/doi/10.1002/14651858.CD001287. pub5 Accessed: 20.11.2015.
(check this in PDF content)
20
Skrepnek G. H., Skrepnek S. V. Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma. Am. J. Manag. Care. 2004; 10 (5): 129-138.
(check this in PDF content)
21
Tashkin D. P., Celli B., Senn S., Burkhart D., Kesten S., Menjoge S., Decramer M. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 2008; 359: 15431554.
(check this in PDF content)
22
Tse H. N., Raiteri L., Wong K. Y., Yee K. S., Ng L. Y., Wai K. Y., Loo C. K., Chan M. H. High-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, pl acebo-controlled HIACE study. Chest. 2013; 144 (1): 106-118. Сведения об авторах:
(check this in PDF content)